Insider Transactions in Q4 2022 at Maia Biotechnology, Inc. (MAIA)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2022
|
Vlad Vitoc Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
410
+0.05%
|
$1,230
$3.5 P/Share
|
|
Dec 30
2022
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
500
+0.1%
|
$1,500
$3.5 P/Share
|
|
Dec 29
2022
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
1,471
+0.29%
|
$4,413
$3.49 P/Share
|
|
Dec 28
2022
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
1,266
+0.25%
|
$3,798
$3.41 P/Share
|
|
Dec 27
2022
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
604
+0.12%
|
$1,812
$3.38 P/Share
|
|
Dec 23
2022
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
981
+0.19%
|
$2,943
$3.45 P/Share
|
|
Dec 22
2022
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
731
+0.14%
|
$2,193
$3.34 P/Share
|
|
Dec 21
2022
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
399
+0.08%
|
$1,197
$3.43 P/Share
|
|
Dec 20
2022
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
4,048
+0.79%
|
$12,144
$3.53 P/Share
|
|
Dec 07
2022
|
Sergei Gryaznov Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+18.34%
|
$10,000
$1.83 P/Share
|